| Followers | 65 |
| Posts | 26907 |
| Boards Moderated | 0 |
| Alias Born | 11/23/2016 |
Monday, December 23, 2024 4:58:16 PM
I suppose that it is good news in the sense that the P2a and P2b/3 peer reviews are not full of disparities of conclusions for EMA to pick holes in.
The longer we wait, the sooner we will get rich!
Recent AVXL News
- Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group • GlobeNewswire Inc. • 10/29/2025 11:30:00 AM
- Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’ • GlobeNewswire Inc. • 10/10/2025 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2025 12:42:50 AM
- Anavex shares climb on upbeat results from schizophrenia trial • IH Market News • 10/02/2025 12:45:17 PM
- Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program • GlobeNewswire Inc. • 10/02/2025 11:35:00 AM
- Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia • GlobeNewswire Inc. • 10/02/2025 11:30:00 AM
- Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial • GlobeNewswire Inc. • 09/30/2025 12:30:00 PM
- Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer’s Disease Trial • GlobeNewswire Inc. • 09/09/2025 11:30:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025 • GlobeNewswire Inc. • 09/02/2025 11:30:00 AM
- Anavex Life Sciences Reports New Publication in Medical Journal Highlighting the Established Precise Autophagy Mechanism with Blarcamesine • GlobeNewswire Inc. • 08/26/2025 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2025 09:30:21 PM
- Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease • GlobeNewswire Inc. • 08/20/2025 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2025 08:08:20 PM
- Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/12/2025 11:30:00 AM
- Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025 • GlobeNewswire Inc. • 08/05/2025 11:30:00 AM
- Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease • GlobeNewswire Inc. • 07/31/2025 11:30:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/25/2025 08:48:24 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/24/2025 04:15:19 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/14/2025 08:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2025 09:25:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2025 09:30:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/09/2025 09:30:47 PM
- Anavex Life Sciences to Participate at Upcoming Healthcare Conferences • GlobeNewswire Inc. • 05/14/2025 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 08:31:17 PM
- Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/13/2025 11:30:00 AM
Isiah Thomas Marks Historic Milestone: First NBA Player With Majority Control of a Public Company • OWPC • Nov 6, 2025 12:23 PM
EVTV Takes Flight in Europe: U.S. Heavy-Lift Drones to Disrupt Traditional Vineyard Operations Across Italy • EVTV • Nov 6, 2025 8:19 AM
Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment • AVAI • Nov 4, 2025 8:46 AM
ECGI Holdings Signs Binding $30 Million LOI to Acquire Licensed Mortgage Lender RezyFi • ECGI • Nov 3, 2025 8:30 AM
One World Products Secures OEM Approval for Cellulose Fiber-Filled Masterbatch for Future Vehicle Programs • OWPC • Nov 3, 2025 8:15 AM
From Explorer to Producer: The Most Compelling Mining Window • ABMBF • Oct 30, 2025 9:00 AM
